Advancements in diagnosis of pulmonary arterial hypertension in scleroderma

Arthritis and Rheumatism

Volumn 52, Issue 12, 2005, Pages 3698-3700

  Steen, Virginia ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; DETERIORATION; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; EDITORIAL; FATALITY; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG FUNCTION TEST; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SCLERODERMA; SYMPTOMATOLOGY;

HUMANS; HYPERTENSION, PULMONARY; SCLERODERMA, SYSTEMIC;

EID: 29144488026     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21613     Document Type: Editorial

References (11)

1. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990;113:35 2-7.
2. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986;29:515-24.
3. Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial. Ann Intern Med 2000;132:425-34.
4. Channick RN, Rubin LJ. New and experimental therapies for pulmonary hypertension. Clin Chest Med 2001;22:539-45.
5. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
6. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-22.
7. Al Sabbagh MR, Steen VD, Zee BC, Nalesnik M, Trostle DC, Bedetti CD, et al. Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study. J Rheumatol 1989;16:1038-42.
8. Steen V. Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003;62:97-9.
9. Steen V. The heart in systemic sclerosis. Curr Rheumatol Rep 2004;6:137-40.
10. Grunig E, Janssen B, Mereles D, Earth U, Borst MM. Vogt IR, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102:1145-50.
11. MacGregor AJ, Canavan R, Knight C, Denton CP. Davar J, Coghlan J, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001;40:453-9.